Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

Extracorporeal photopheresis (ECP) has been used for over 20 years to treat acute GVHD
(aGVHD) and chronic GVHD. Evidence on the efficacy of response in aGVHD has continued …

This comprehensive case series illustrates the findings on 2-deoxy-2-[F-18] fluoro-d-glucose
(FDG) positron-emission tomography/computed tomography (PET/CT) of patients with …

Extracorporeal photochemotherapy (ECP) is a well established treatment for both cutaneous
T cell lymphoma (CTCL) and graft-versus-host disease (GVHD). However, the general …

1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of
cutaneous T‐cell lymphoma by extracorporeal photochemotherapy: preliminary results. N …

Dermatologists are typically involved when patients present with the initial signs of
cutaneous T-cell lymphoma (CTCL). The earliest phases of the disease are characterized by …

Methods. Using standard apheresis procedure, 300 mL of plasma and 240 mL of buffy coat
were collected and diluted with 200 mL of saline. The enriched lymphocyte solution was …

Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy and
extracorporeal photoimmunotherapy, initially demonstrated a therapeutic impact on …

Overview Acute graft versus host disease (aGVHD) is a key complication of haematopoietic
stem-cell transplantation. The main first-line therapy is steroids, however less than half of …

Extracorporeal photokjemoterapi (ECP) har blitt akseptert som behandling av enkelte T celle
medierte tilstander, som kutant T celle lymfom (CTCL) og Graft-vs-Host disease (GVHD) …